• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Nuclear Import of JAK1 Is Mediated by a Classical NLS and Is Required for Survival of Diffuse Large B-cell Lymphoma.JAK1的核输入由经典核定位信号介导,是弥漫性大B细胞淋巴瘤存活所必需的。
Mol Cancer Res. 2017 Mar;15(3):348-357. doi: 10.1158/1541-7786.MCR-16-0344. Epub 2016 Dec 28.
2
Epigenetic gene regulation by Janus kinase 1 in diffuse large B-cell lymphoma.Janus激酶1在弥漫性大B细胞淋巴瘤中的表观遗传基因调控
Proc Natl Acad Sci U S A. 2016 Nov 15;113(46):E7260-E7267. doi: 10.1073/pnas.1610970113. Epub 2016 Oct 31.
3
JAKs go nuclear: emerging role of nuclear JAK1 and JAK2 in gene expression and cell growth.JAK蛋白进入细胞核:细胞核内JAK1和JAK2在基因表达及细胞生长中的新作用
Growth Factors. 2011 Dec;29(6):245-52. doi: 10.3109/08977194.2011.614949. Epub 2011 Sep 5.
4
Oncogenically active MYD88 mutations in human lymphoma.人类淋巴瘤中致癌性激活的 MYD88 突变。
Nature. 2011 Feb 3;470(7332):115-9. doi: 10.1038/nature09671. Epub 2010 Dec 22.
5
Cytokine receptor signaling is required for the survival of ALK- anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations.细胞因子受体信号对于 ALK-间变性大细胞淋巴瘤的存活是必需的,即使存在 JAK1/STAT3 突变也是如此。
Proc Natl Acad Sci U S A. 2017 Apr 11;114(15):3975-3980. doi: 10.1073/pnas.1700682114. Epub 2017 Mar 29.
6
Nuclear Respiratory Factor 2β (NRF-2β) recruits NRF-2α to the nucleus by binding to importin-α:β via an unusual monopartite-type nuclear localization signal.核呼吸因子 2β(NRF-2β)通过与输入蛋白-α:β 结合的非典型单部分型核定位信号将 NRF-2α 募集到细胞核内。
J Mol Biol. 2013 Sep 23;425(18):3536-48. doi: 10.1016/j.jmb.2013.07.007. Epub 2013 Jul 13.
7
PIM kinases are progression markers and emerging therapeutic targets in diffuse large B-cell lymphoma.PIM 激酶是弥漫性大 B 细胞淋巴瘤的进展标志物和新兴治疗靶点。
Br J Cancer. 2012 Jul 24;107(3):491-500. doi: 10.1038/bjc.2012.272. Epub 2012 Jun 21.
8
Distinct IL-4-induced gene expression, proliferation, and intracellular signaling in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas.生发中心B细胞样和活化B细胞样弥漫性大细胞淋巴瘤中白细胞介素-4诱导的独特基因表达、增殖及细胞内信号传导
Blood. 2005 Apr 1;105(7):2924-32. doi: 10.1182/blood-2004-10-3820. Epub 2004 Dec 9.
9
Constitutive BR3 receptor signaling in diffuse, large B-cell lymphomas stabilizes nuclear factor-κB-inducing kinase while activating both canonical and alternative nuclear factor-κB pathways.弥漫性大 B 细胞淋巴瘤中 BR3 受体的组成性信号转导稳定了核因子-κB 诱导激酶,同时激活了经典和替代的核因子-κB 途径。
Blood. 2011 Jan 6;117(1):200-10. doi: 10.1182/blood-2010-06-290437. Epub 2010 Oct 1.
10
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma.弥漫性大 B 细胞淋巴瘤中慢性活性 B 细胞受体信号转导。
Nature. 2010 Jan 7;463(7277):88-92. doi: 10.1038/nature08638.

引用本文的文献

1
FERM domain-containing proteins are active components of the cell nucleus.FERM 结构域蛋白是细胞核的活性成分。
Life Sci Alliance. 2024 Jan 31;7(4). doi: 10.26508/lsa.202302489. Print 2024 Apr.
2
Double-edged sword of JAK/STAT signaling pathway in viral infections: novel insights into virotherapy.JAK/STAT 信号通路在病毒感染中的双刃剑作用:病毒治疗的新见解。
Cell Commun Signal. 2023 Oct 2;21(1):272. doi: 10.1186/s12964-023-01240-y.
3
The Seminiferous Epithelial Cycle of Spermatogenesis: Role of Non-receptor Tyrosine Kinases.精子发生的生精上皮周期:非受体酪氨酸激酶的作用。
Adv Exp Med Biol. 2021;1288:1-20. doi: 10.1007/978-3-030-77779-1_1.
4
EGR1 Addiction in Diffuse Large B-cell Lymphoma.EGR1 成瘾在弥漫性大 B 细胞淋巴瘤中的作用。
Mol Cancer Res. 2021 Aug;19(8):1258-1269. doi: 10.1158/1541-7786.MCR-21-0267. Epub 2021 May 12.
5
Identification of a 14-Gene Prognostic Signature for Diffuse Large B Cell Lymphoma (DLBCL).弥漫性大B细胞淋巴瘤(DLBCL)14基因预后特征的鉴定
Front Genet. 2021 Feb 10;12:625414. doi: 10.3389/fgene.2021.625414. eCollection 2021.
6
JAK3 Is Expressed in the Nucleus of Malignant T Cells in Cutaneous T Cell Lymphoma (CTCL).JAK3在皮肤T细胞淋巴瘤(CTCL)的恶性T细胞核中表达。
Cancers (Basel). 2021 Jan 14;13(2):280. doi: 10.3390/cancers13020280.
7
Targeting nuclear import and export in hematological malignancies.靶向血液系统恶性肿瘤的核输入和输出。
Leukemia. 2020 Nov;34(11):2875-2886. doi: 10.1038/s41375-020-0958-y. Epub 2020 Jul 5.
8
STAT3 Activation and Oncogenesis in Lymphoma.淋巴瘤中的信号转导和转录激活因子3(STAT3)激活与肿瘤发生
Cancers (Basel). 2019 Dec 19;12(1):19. doi: 10.3390/cancers12010019.
9
Janus Kinase 1 Is Required for Transcriptional Reprograming of Murine Astrocytes in Response to Endoplasmic Reticulum Stress.内质网应激反应中,小鼠星形胶质细胞转录重编程需要Janus激酶1 。
Front Cell Neurosci. 2019 Oct 11;13:446. doi: 10.3389/fncel.2019.00446. eCollection 2019.
10
Glutaminolysis Mediated by MALT1 Protease Activity Facilitates PD-L1 Expression on ABC-DLBCL Cells and Contributes to Their Immune Evasion.由MALT1蛋白酶活性介导的谷氨酰胺分解促进ABC-DLBCL细胞上PD-L1的表达并有助于其免疫逃逸。
Front Oncol. 2018 Dec 18;8:632. doi: 10.3389/fonc.2018.00632. eCollection 2018.

本文引用的文献

1
Epigenetic gene regulation by Janus kinase 1 in diffuse large B-cell lymphoma.Janus激酶1在弥漫性大B细胞淋巴瘤中的表观遗传基因调控
Proc Natl Acad Sci U S A. 2016 Nov 15;113(46):E7260-E7267. doi: 10.1073/pnas.1610970113. Epub 2016 Oct 31.
2
A mix of S and ΔS variants of STAT3 enable survival of activated B-cell-like diffuse large B-cell lymphoma cells in culture.信号转导和转录激活因子3(STAT3)的S型和ΔS型变体组合可使活化B细胞样弥漫性大B细胞淋巴瘤细胞在培养中存活。
Oncogenesis. 2016 Jan 4;4(1):e184. doi: 10.1038/oncsis.2015.44.
3
Instructive roles for cytokine-receptor binding parameters in determining signaling and functional potency.细胞因子受体结合参数在决定信号传导和功能效力方面的指导作用。
Sci Signal. 2015 Nov 10;8(402):ra114. doi: 10.1126/scisignal.aab2677.
4
Distinct Acute Lymphoblastic Leukemia (ALL)-associated Janus Kinase 3 (JAK3) Mutants Exhibit Different Cytokine-Receptor Requirements and JAK Inhibitor Specificities.不同的急性淋巴细胞白血病(ALL)相关的Janus激酶3(JAK3)突变体表现出不同的细胞因子受体需求和JAK抑制剂特异性。
J Biol Chem. 2015 Nov 27;290(48):29022-34. doi: 10.1074/jbc.M115.670224. Epub 2015 Oct 7.
5
IPO3-mediated Nonclassical Nuclear Import of NF-κB Essential Modulator (NEMO) Drives DNA Damage-dependent NF-κB Activation.IPO3介导的核因子κB必需调节因子(NEMO)的非经典核输入驱动DNA损伤依赖性核因子κB激活。
J Biol Chem. 2015 Jul 17;290(29):17967-17984. doi: 10.1074/jbc.M115.645960. Epub 2015 Jun 9.
6
Targeting JAK kinase in solid tumors: emerging opportunities and challenges.靶向实体瘤中的JAK激酶:新出现的机遇与挑战。
Oncogene. 2016 Feb 25;35(8):939-51. doi: 10.1038/onc.2015.150. Epub 2015 May 18.
7
The JAK-STAT pathway: impact on human disease and therapeutic intervention.JAK-STAT信号通路:对人类疾病的影响及治疗干预
Annu Rev Med. 2015;66:311-28. doi: 10.1146/annurev-med-051113-024537.
8
Mechanism of activation of protein kinase JAK2 by the growth hormone receptor.生长激素受体激活蛋白激酶 JAK2 的机制。
Science. 2014 May 16;344(6185):1249783. doi: 10.1126/science.1249783.
9
Targeting the β-catenin nuclear transport pathway in cancer.针对癌症中的β-连环蛋白核转运途径。
Semin Cancer Biol. 2014 Aug;27:20-9. doi: 10.1016/j.semcancer.2014.04.012. Epub 2014 May 9.
10
JAKs and STATs in immunity, immunodeficiency, and cancer.免疫、免疫缺陷和癌症中的JAKs与STATs
N Engl J Med. 2013 Jan 10;368(2):161-70. doi: 10.1056/NEJMra1202117.

JAK1的核输入由经典核定位信号介导,是弥漫性大B细胞淋巴瘤存活所必需的。

Nuclear Import of JAK1 Is Mediated by a Classical NLS and Is Required for Survival of Diffuse Large B-cell Lymphoma.

作者信息

Zhu Fen, Hwang Byounghoon, Miyamoto Shigeki, Rui Lixin

机构信息

Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.

Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.

出版信息

Mol Cancer Res. 2017 Mar;15(3):348-357. doi: 10.1158/1541-7786.MCR-16-0344. Epub 2016 Dec 28.

DOI:10.1158/1541-7786.MCR-16-0344
PMID:28031410
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5473959/
Abstract

JAKs are non-receptor tyrosine kinases that are generally found in association with cytokine receptors. In the canonical pathway, roles of JAKs have well been established in activating STATs in response to cytokine stimulation to modulate gene transcription. In contrast, a noncanonical role of JAK2 has recently been discovered, in which JAK2 in the nucleus imparts the epigenetic regulation of gene transcription through phosphorylation of tyrosine 41 on the histone protein H3. Recent work further demonstrated that this noncanonical mechanism is conserved with JAK1, which is activated by the autocrine cytokines IL6 and IL10 in activated B-cell-like diffuse large B-cell lymphoma (ABC DLBCL), a cancer type that is particularly difficult to treat and has poor prognosis. However, how JAK1 gains access to the nucleus to enable epigenetic regulation remains undefined. Here, we investigated this question and revealed that JAK1 has a classical nuclear localization signal toward the N-terminal region, which can be recognized by multiple importin α isoforms. Moreover, the nuclear import of JAK1 is independent of its kinase activity but is required for the optimal expansion of ABC DLBCL cells This study demonstrates that the nuclear import of JAK1 is essential for the optimal fitness of ABC DLBCL cells, and targeting JAK1 nuclear localization is a potential therapeutic strategy for ABC DLBCL. .

摘要

JAKs是非受体酪氨酸激酶,通常与细胞因子受体相关联。在经典途径中,JAKs在响应细胞因子刺激激活STATs以调节基因转录方面的作用已得到充分确立。相比之下,最近发现了JAK2的一种非经典作用,即细胞核中的JAK2通过组蛋白H3上酪氨酸41的磷酸化赋予基因转录的表观遗传调控。最近的研究进一步表明,这种非经典机制在JAK1中是保守的,JAK1在活化B细胞样弥漫性大B细胞淋巴瘤(ABC DLBCL)中被自分泌细胞因子IL6和IL10激活,ABC DLBCL是一种特别难以治疗且预后较差的癌症类型。然而,JAK1如何进入细胞核以实现表观遗传调控仍不清楚。在这里,我们研究了这个问题,并发现JAK1在其N端区域有一个经典的核定位信号,可被多种输入蛋白α异构体识别。此外,JAK1的核输入与其激酶活性无关,但对于ABC DLBCL细胞的最佳增殖是必需的。这项研究表明,JAK1的核输入对于ABC DLBCL细胞的最佳适应性至关重要,靶向JAK1核定位是ABC DLBCL的一种潜在治疗策略。